Cargando…
Thiosemicarbazide Derivatives Targeting Human TopoIIα and IDO-1 as Small-Molecule Drug Candidates for Breast Cancer Treatment
In 2020, breast cancer became the most frequently diagnosed type of cancer, with nearly 2.3 million new cases diagnosed. However, with early diagnosis and proper treatment, breast cancer has a good prognosis. Here, we investigated the effect of thiosemicarbazide derivatives, previously identified as...
Autores principales: | Kaproń, Barbara, Czarnomysy, Robert, Radomska, Dominika, Bielawski, Krzysztof, Plech, Tomasz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051798/ https://www.ncbi.nlm.nih.gov/pubmed/36982886 http://dx.doi.org/10.3390/ijms24065812 |
Ejemplares similares
-
EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumors to TopoII inhibitors
por: Fillmore, Christine M., et al.
Publicado: (2015) -
Identification of the first-in-class dual inhibitors of human DNA topoisomerase IIα and indoleamine-2,3-dioxygenase 1 (IDO 1) with strong anticancer properties
por: Kaproń, Barbara, et al.
Publicado: (2022) -
Aquaporin 1 promotes sensitivity of anthracycline chemotherapy in breast cancer by inhibiting β-catenin degradation to enhance TopoIIα activity
por: Chong, Wei, et al.
Publicado: (2020) -
TopoIIα prevents telomere fragility and formation of ultra thin DNA bridges during mitosis through TRF1-dependent binding to telomeres
por: d’Alcontres, Martina Stagno, et al.
Publicado: (2014) -
Lipophilicity Studies on Thiosemicarbazide Derivatives
por: Paneth, Agata, et al.
Publicado: (2017)